PROCR and neoplasm: While EPCR plays important roles in regulating the host defense to infection [59]–[61], there are no conclusive data to indicate that long term blockade of EPCR or loss of EPCR [38] increases the risk of thrombosis and would limit the application of inhibitory antibodies to EPCR to block tumor growth.